Д.Цэнд-Аюуш
Loading...
Товч нэр
Д.Цэнд-Аюуш
Бүтэн нэр
Дамба Цэнд-Аюуш
Латин нэр
Damba Tsend-Ayush
Албан тушаал
Захирал
Эрдмийн цол
Профессор
Боловсролын зэрэг
Доктор (Ph.D)
20 results
Now showing 1 - 10 of 20
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Study on Preparation Technology and Safety Evaluation of Hataagqi-19 Hydrogel Patch(Mongolian National University of Medical Sciences, 2021-12-31) ;Aruhan ;Byambasuren Dorjsuren ;Xiaoling Song ;Chimedragchaa ChimedtserenMinhui LiObjectives: The study objective of the present study was to screen the dosage of matrix material and clarify the safety evaluation of Hataagqi-19 hydrogel patch. Methods: Single factor and orthogonal experiments were used to screen, and the best matrix ratio was screened out with peel strength, peel ability, viscosity, spread ability, uniformity, as evaluation indicators. Long term toxicity test was carried out in SD rats in order to test general conditions such as: body weight, food intake, electrocardiogram, blood, urine, and biochemical indicators, organ coefficients and histopathological changes. Moreover, skin allergic reaction tests were done to observe the allergic responce. Results: The ratio of the gel patch matrix is NP-700: aluminum glycolate: glycerol: carbomer = 6: 0.35: 35: 0.40; the ratio of azone and propylene glycol is 1: 1, and the total penetration enhancer dosage is 5%. Hataagqi-19 preparation had no obvious long-term toxicity or skin allergies. Conclusions: The Hataagqi-19 hydrogel patch prepared with the best ratio and transdermal agent showed good performance and safety. Furthermore, we did not observed toxic side effects, and the preparation process is feasible and reliable. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Topical Meconium Improves Barrier Repair and Reduces Skin Inflammation in a Rat Model of Eczema(2025-12-15) ;Anudari Ichinkhorloo ;Khuslen Batzorig; ;Batbold BatsaikhanEczema, or atopic dermatitis, is a chronic inflammatory skin condition characterized by epidermal barrier dysfunction and immune dysregulation. While traditionally considered a waste product, meconium—the first stool of neonates—contains various bioactive compounds that may influence immune responses and epithelial integrity. This study investigates the dermatological effects of meconium in a chemically induced eczema model in Wistar rats, focusing on its potential to modulate inflammation and promote skin barrier repair. Meconium samples were collected from healthy neonates and applied topically to rats with Veet-induced eczema. The experimental groups included untreated eczema controls, meconium-treated rats, Meebo ointment-treated rats (positive control), and a healthy control group. Clinical assessments of erythema, ulceration, and edema were conducted, alongside histopathological evaluations of epidermal thickness and immune cell infiltration. Statistical analyses were performed using ANOVA with post-hoc Tukey tests. Meconium treatment significantly reduced erythema and ulceration scores compared to untreated eczema controls (p<0.01) and increased epidermal thickness (p<0.05). While less effective than Meebo ointment, meconium demonstrated notable anti-inflammatory and regenerative properties. The findings suggest that meconium contains bioactive components capable of modulating skin inflammation and enhancing barrier repair, warranting further investigation into its potential therapeutic applications in dermatological conditions. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Hepatoprotective Activity of the Traditional Multicomponent Formulation Gurgem-13 on Carbon Tetrachloride (CCL4) Induced Experimental Liver Injury in Rats(Mongolian National University of Medical Sciences, 2019-12-29); ;Chimedragchaa Chimedtseren; Altantsetseg AltangerelObjectives: The purpose of present study was intended to evaluate hepatoprotective effects of traditional multicomponent formulation Gurgum13 on carbon tetrachloride (CCI4) induced liver injury model in rats. Methods: Chronic toxic liver injury was induced experimentally by intraperitoneal injection (IP) of 1.0 ml/kg body weight of 10% carbon tetrachloride (CCI4) three times per week for duration of three months in rats. A total of five groups of animals with 15 rats in each were used for the experiment. Group 1 was as a normal control (intact). Group 2 served as a control group received CCI4 1.0 ml/kg IP three times a week for 3 months. Group 3, 4 and 5 were as the treatment groups received CCI4 1 ml/kg IP and administered traditional multicomponent formulation Gurgum-13 as a test drug (100 mg/kg) for 3 months daily. Milk thistle (50 mg/kg) and Lilicoaguliant (LLC) (100 mg/kg) were given daily for 3 months as a reference drug respectively. The activity of Gurgum-13 formulation and other comparative drugs were investigated with the dynamic study of liver marker enzymes, AST, ALT, ALP, bilirubin, and the antioxidant and blood coagulating effects of the remedy, which were studied in three months of experimentation. Gurgum-13 is one of the Mongolian traditional multicomponent formulation used in practice for a range of diseases including liver disorders. Results: Carbon tetrachloride significantly decreased the liver functions as assessed through an increase in blood serum and liver marker enzymes in control groups. Gurgum-13 treatment significantly prevented hepatotoxicity of carbon tetrachloride by reducing ALT, AST, ALP marker enzymes and bilirubin in blood serum and liver tissue in the three months period of chronic hepatitis (p<.05) similar to reference drugs. The result of the study revealed that Gurgum-13 is significant hepatoprotective against liver injury from CCI4 induced hepatotoxicity by having antioxidant effect and decreasing lipid peroxidation in liver. Conclusion: Multicomponent traditional formulation Gurgum-13 demonstrated very good hepatoprotective effect against CCI4 induced liver injury in rats. Thus, Gurgum-13 can be an effective remedy for the treatment of chronic hepatitis and biliary tract disorders. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Hepatoprotective Effect of Silymarin Peptide on Carbon Tetrachloride-Induced Acute Liver Injury in Mice(Mongolian National University of Medical Sciences, 2024-09-27) ;Ananda Ananda; ;Xiulan SuObjective: Liver diseases and injuries are significant global health concerns; in particular, acute liver injury (ALI) is a prominent cause of liver diseases and is associated with high morbidity and mortality. The application of natural products in preventing and treating liver diseases is considerable. Silymarin and silymarin peptides derive from the Milk thistle (Silybum marianum). Still, they differ in their composition and effects: Silymarin is a complex mixture of flavonoids, primarily made up of silybinin, silybinin, and silychristin. Silymarin is well-known for its antioxidant, anti-inflammatory, and hepatoprotective properties. It is often a dietary supplement to support liver health. Silymarin Peptide refers to specific peptides derived from silymarin. These peptides have more enhanced bioavailability and activity of effect compared to the whole silymarin compound. Therefore, this study aimed to investigate the hepatoprotective effects of silymarin peptide on acute liver injury (ALI) in mice induced by carbon tetrachloride (CCl4) compared withSilymarin. Methods: Forty-eight male C57BL/6J mice were randomly divided into six groups (n=8 per group): Control group: regular saline+olive oil, Negative control group: 10% CCl4 solution (10 μl/g), Treatment group 1: CCl4+50 mg/kg silymarin peptide, Treatment group 2: CCl4+100 mg/kg silymarin peptide, Treatment group 3: CCl4+200 mg/kg silymarin peptide, and Positive control group: CCl4+100 mg/kg silymarin. The treatment of silymarin was used as a positive control. At the end of the experiments, mice were euthanized, and the blood and liver samples were collected. Results: The results showed that silymarin peptide ameliorated the histopathological damage of liver tissues caused by CCl4 and decreased the CCl4-induced serum AST and ALT levels, among which the 200 mg/kg dose demonstrated the most notable protective effect. Additionally, silymarin peptide showed no significant influence on CCL2 levels but markedly reduced TNF-α and CXCL5 levels, with the most apparent impact at 100 mg/kg. Finally, the terminal deoxynucleotidyl transferase‐mediated dUTP‐nick end labeling (TUNEL) staining indicated that the 200 mg/kg dose of silymarin peptide restrained CCl4-induced hepatocytic apoptosis. Conclusion: Silymarin peptide alleviated CCl4-induced ALI in mice byinhibiting inflammatory cytokines release and decreasing hepatocyte apoptosis. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Topical Meconium Improves Barrier Repair and Reduces Skin Inflammation in a Rat Model of Eczema(2025-12-30) ;Anudari Ichinkhorloo ;Khuslen Batzorig; ;Batbold BatsaikhanEczema, or atopic dermatitis, is a chronic inflammatory skin condition characterized by epidermal barrier dysfunction and immune dysregulation. While traditionally considered a waste product, meconium—the first stool of neonates—contains various bioactive compounds that may influence immune responses and epithelial integrity. This study investigates the dermatological effects of meconium in a chemically induced eczema model in Wistar rats, focusing on its potential to modulate inflammation and promote skin barrier repair. Meconium samples were collected from healthy neonates and applied topically to rats with Veet-induced eczema. The experimental groups included untreated eczema controls, meconium-treated rats, Meebo ointment-treated rats (positive control), and a healthy control group. Clinical assessments of erythema, ulceration, and edema were conducted, alongside histopathological evaluations of epidermal thickness and immune cell infiltration. Statistical analyses were performed using ANOVA with post-hoc Tukey tests. Meconium treatment significantly reduced erythema and ulceration scores compared to untreated eczema controls (p<0.01) and increased epidermal thickness (p<0.05). While less effective than Meebo ointment, meconium demonstrated notable anti-inflammatory and regenerative properties. The findings suggest that meconium contains bioactive components capable of modulating skin inflammation and enhancing barrier repair, warranting further investigation into its potential therapeutic applications in dermatological conditions. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Topical Meconium Improves Barrier Repair and Reduces Skin Inflammation in a Rat Model of Eczema(2025-12-15) ;Anudari Ichinkhorloo ;Khuslen Batzorig; ;Batbold BatsaikhanEczema, or atopic dermatitis, is a chronic inflammatory skin condition characterized by epidermal barrier dysfunction and immune dysregulation. While traditionally considered a waste product, meconium—the first stool of neonates—contains various bioactive compounds that may influence immune responses and epithelial integrity. This study investigates the dermatological effects of meconium in a chemically induced eczema model in Wistar rats, focusing on its potential to modulate inflammation and promote skin barrier repair. Meconium samples were collected from healthy neonates and applied topically to rats with Veet-induced eczema. The experimental groups included untreated eczema controls, meconium-treated rats, Meebo ointment-treated rats (positive control), and a healthy control group. Clinical assessments of erythema, ulceration, and edema were conducted, alongside histopathological evaluations of epidermal thickness and immune cell infiltration. Statistical analyses were performed using ANOVA with post-hoc Tukey tests. Meconium treatment significantly reduced erythema and ulceration scores compared to untreated eczema controls (p<0.01) and increased epidermal thickness (p<0.05). While less effective than Meebo ointment, meconium demonstrated notable anti-inflammatory and regenerative properties. The findings suggest that meconium contains bioactive components capable of modulating skin inflammation and enhancing barrier repair, warranting further investigation into its potential therapeutic applications in dermatological conditions. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Blood Donors with Different Types of Human Constitution Demonstrate Different Level of Cytokines(Mongolian National University of Medical Sciences, 2018-06-25); ;Soodoi, Chimedtseren; ; Objective: This study was aimed to determine possible relationship between the types of human constitution used in Mongolian traditional medicine and certain types of immune response in healthy blood donors. Materials and methods: Ninety-three blood donors were enrolled in this cross-sectional study. The type of human constitution was determined using the method of Sachs R (1995) and modifi ed by Batchimeg et al. (2003), in which the titer of cytokines (Human IL-2, IL-6, IL-10, IFNγ and TGFβ) in blood plasma and in supernatant of 12- hour PBMC culture were measured by ELISA. Results: Analysis and comparison of different cytokine titers in different constitution groups produced the following fi ndings: Subjects with Badgan ( Tibetan-badken, or phlegm, or bile) type of constitution had a lower activity of Th2 mediated immune response; subjects with Shar ( Tibetan-mkrispa [kris-pa] or mucus) humour domination had a higher activity of Th2 mediated response; and subjects with Khii humour domination may demonstrate higher activity of Th1 mediated response. Conclusion: Human typology types used in Mongolian traditional medicine are likely related to activity or intensity of certain types of adaptive immune responses and authors see an essential need to continue research in this fi eld of study. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effects of Hepaclin-4 on Hepatocellular Carcinoma (Hep G2)(Mongolian National University of Medical Sciences, 2018-03-25); ;Naranbat, Nergui; ; Objective: Liver cancer is the fifth most frequent cancer worldwide and is usually diagnosed at an advanced stage. Natural products play an important role in anticancer drug therapy because they are effective in treating specific characteristics of cancer while also effective at reducing side effects. However, the cytotoxicity and anti-proliferative effects of Scutellaria baicalensis Georgi, Saussurea amara L, Chiazospermum erectum (L) Bernh, Carthamus tinctorius L., remain unclear. Our research aims to investigate the anti-cancer properties of Hepaclin-4 (Hep-4) extracts from the above mentioned plants. Methods: To evaluate the in vitro cytotoxicity of Hep-4, an ethanol extract of Hep-4 (500, 250, 125, 100, 50, and 10 μg/mL)L, doxorubicin, and 5-fluorouracil (5-FU) were assessed against the Hep G2 hepatocarcinoma cell line by monitoring proliferation using the MTT assay method. Results: The results demonstrated growth inhibition of cells in both dose-and time-dependent manners. Hep-4 inhibited Hep G2 transformation in 45% and the comparative group, 5-FU, effects on 40% of it. Conclusion: Our findings suggest that Hep-4 extracts have the potential to be a potent cytotoxic agent against Hep G2 cells, as it has commendable anti-proliferative effects against hepatocarcinoma cell lines and can be considered an effective adjuvant therapeutic agent. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Distribution of Human Constitutional Types Used In Traditional Mongolian Medicine among Patients with Chronic Hepatitis B(SciVision Publishers LLC, 2018-12-30); ;Li, Yong; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effects of Mongolian Medicine Modified Sugmul-7 on Hyperplasia of the Breast(Mongolian National University of Medical Sciences, 2021-09-30); ; ; ;Tuul KhalzaibaastGong JuhuaObjectives: The aim of this study was to explore the mechanism of regulating the endocrine function of hyperplasia breast in rats with Mongolian Medicine Modified Sugmul-7 (MMMS-7) by Proteomics and provide an experimental basis for its development and clinical application. Methods: Ninety female SD rats were randomly divided into 6 groups: the intact group – the animal group that was injected with neither estradiol, nor progesterone, nor administered Mongolian Medicine Modified Sugmul-7; the negative control group – the group injected with estradiol and progesterone; the positive control group - injected with estradiol, progesterone and administered mastodynon 0.06 g/kg; and the treatment groups – injected with estradiol and progesterone, each in their respective dose groups. After the start of the experiment, each rat except the intact group was intra peritoneally injected with estradiol 25d and progesterone 6d at a standard dose of 0.3 mg / kg for a total of 31 days. Results: Four differential proteins were found through proteomic analysis, namely Ppp3cb, Cacybp, Gstz1, and Nmd3 and their 5 related pathways. Conclusions: The above pathways are all known to be related to the treatment of breast hyperplasia caused by endocrine disorders. Treatment with Mongolian Medicine Modified Sugmul-7 is completed through regulation of the gastrointestinal and endocrine systems.
